The Molecular Constituents of the Blood-Brain Barrier

Trends in Neurosciences

Volumn 38, Issue 10, 2015, Pages 598-608

  Chow, Brian Wai ^a   Gu, Chenghua ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM CELL; MICROENVIRONMENT; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; HUMANS;

EID: 84943237109     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2015.08.003     Document Type: Review

References (80)

1. Andreone B.J., et al. Neuronal and vascular interactions. Annu. Rev. Neurosci. 2015, 38:25-46.
2. Obermeier B., et al. Development, maintenance and disruption of the blood-brain barrier. Nat. Med. 2013, 19:1584-1596.
3. Ehrlich P. Das Sauerstoff-Bedürfniss des Organismus. Eine farbenanalytische Studie 1885, Hirschwald, (in German).
4. Ehrlich P. Ueber die Beziehungen von chemischer Constitution, Verteilung und pharmakologischer Wirkung. Gesammelte Arbeiten zur Immunitaetsforschung 1904, 574. Hirschwald, (in German).
5. Goldmann E.E. Die äussere und innere Skeretion des gesunden Organismus im Lichte der "vitalen Färbung" 1909, H. Laupp'schen, (in German).
6. Vein A.A. Science and fate: Lina Stern (1878-1968), a neurophysiologist and biochemist. J. Hist. Neurosci. 2008, 17:195-206.
7. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34:207-217.
8. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 1969, 40:648-677.
9. Betz A.L., Goldstein G.W. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 1978, 202:225-227.
10. Daneman R., Prat A. The blood-brain barrier. Cold Spring Harb. Perspect. Biol. 2015, 7:a020412.
11. Pappenheimer J.R. Filtration, diffusion and molecular sieving through peripheral capillary membranes. A contribution to the pore theory of capillary permeability. Am. J. Physiol. 1951, 167:1-34.
12. Siegenthaler J.A., et al. "Sealing off the CNS": cellular and molecular regulation of blood-brain barriergenesis. Curr. Opin. Neurobiol. 2013, 23:1057-1064.
13. Liu W-Y., et al. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci. Ther. 2012, 18:609-615.
14. Balda M.S., Matter K. Tight junctions and the regulation of gene expression. Biochim. Biophys. Acta 2009, 1788:761-767.
15. Tietz S., Engelhardt B. Brain barriers: crosstalk between complex tight junctions and adherens junctions. J. Cell Biol. 2015, 209:493-506.
16. Tuma P.L., Hubbard A.L. Transcytosis: crossing cellular barriers. Physiol. Rev. 2003, 83:871-932.
17. Xiao G., Gan L-S. Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol. 2013, 2013:1-14.
18. Schinkel A.H., et al. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 1995, 96:1698-1705.
19. Schinkel A.H., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
20. Löscher W., Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog. Neurobiol. 2005, 76:22-76.
21. Simpson I.A., et al. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007, 27:1766-1791.
22. Saunders N.R., et al. Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol. Aspects Med. 2013, 34:742-752.
23. César-Razquin A., et al. A call for systematic research on solute carriers. Cell 2015, 162:478-487.
24. Engelhardt B., Ransohoff R.M. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012, 33:579-589.
25. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012, 12:623-635.
26. Muldoon L.L., et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J. Cereb. Blood Flow Metab. 2013, 33:13-21.
27. Hagan N., Ben-Zvi A. The molecular, cellular, and morphological components of blood-brain barrier development during embryogenesis. Semin. Cell Dev. Biol. 2014, 38:7-15.
28. Stewart P.A., Wiley M.J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. 1981, 84:183-192.
29. Stenman J.M., et al. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 2008, 322:1247-1250.
30. Liebner S., et al. Wnt/β-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008, 183:409-417.
31. Daneman R., et al. Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:641-646.
32. Wang Y., et al. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 2012, 151:1332-1344.
33. Zhou Y., et al. Canonical WNT signaling components in vascular development and barrier formation. J. Clin. Invest. 2014, 124:3825-3846.
34. Zhou Y., Nathans J. Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev. Cell 2014, 31:248-256.
35. Kuhnert F., et al. Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science 2010, 330:985-989.
36. Posokhova E., et al. GPR124 functions as a WNT7-specific coactivator of canonical β-catenin signaling. Cell Rep. 2015, 10:123-130.
37. Anderson K.D., et al. Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2807-2812.
38. Cullen M., et al. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5759-5764.
39. Vanhollebeke B., et al. Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/β-catenin pathway during brain angiogenesis. Elife 2015, Published online June 8, 2015. 10.7554/eLife.06489.
40. Chen J., et al. Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice. PLoS ONE 2012, 7:e30203.
41. Tam S.J., et al. Death receptors DR6 and TROY regulate brain vascular development. Dev. Cell 2012, 22:403-417.
42. Ben-Zvi A., et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 2014, 509:507-511.
43. Zhao Z., Zlokovic B.V. Blood-brain barrier: a dual life of MFSD2A?. Neuron 2014, 82:728-730.
44. Betsholtz C. Physiology: double function at the blood-brain barrier. Nature 2014, 509:432-433.
45. Nguyen L.N., et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014, 509:503-506.
46. Lafourcade M., et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 2011, 14:345-350.
47. Guemez-Gamboa A., et al. Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome. Nat. Genet. 2015, 47:809-813.
48. Alakbarzade V., et al. A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome. Nat. Genet. 2015, 47:814-817.
49. Winkler E.A., et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci. 2015, 18:521-530.
50. Zheng P-P., et al. Glut1/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann. Neurol. 2010, 68:835-844.
51. Sohet F., et al. LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J. Cell Biol. 2015, 208:703-711.
52. Daneman R., et al. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 2010, 5:e13741.
53. Yen F.T., et al. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice. J. Biol. Chem. 2008, 283:25650-25659.
54. Nitta T., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
55. Alvarez J.I., et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011, 334:1727-1731.
56. Martí E., Bovolenta P. Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci. 2002, 25:89-96.
57. Braniste V., et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 2014, 6:263ra158.
58. Hsiao E.Y., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155:1451-1463.
59. Al-Asmakh M., Hedin L. Microbiota and the control of blood-tissue barriers. Tissue Barriers 2015, Published online May 29, 2015. 10.1080/21688370.2015.1039691.
60. Brouwer M.C., et al. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin. Microbiol. Rev. 2010, 23:467-492.
61. van Sorge N.M., Doran K.S. Defense at the border: the blood-brain barrier versus bacterial foreigners. Future Microbiol. 2012, 7:383-394.
62. Kim B.J., et al. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J. Clin. Invest. 2015, 125:2473-2483.
63. Zhang Y., et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 2014, 34:11929-11947.
64. Gross P.M., et al. The microcirculation of rat circumventricular organs and pituitary gland. Brain Res. Bull. 1987, 18:73-85.
65. Johnson A.K., Gross P.M. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993, 7:678-686.
66. Broadwell R.D., Brightman M.W. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J. Comp. Neurol. 1976, 166:257-283.
67. Huntley M.A., et al. Dissecting gene expression at the blood-brain barrier. Front. Neurosci. 2014, 8:355.
68. Sander J.D., Joung J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 2014, 32:347-355.
69. Wilhelm I., et al. In vitro models of the blood-brain barrier. Acta Neurobiol. Exp. (Wars.) 2011, 71:113-128.
70. Hatherell K., et al. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J. Neurosci. Methods 2011, 199:223-229.
71. Paolinelli R., et al. Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS ONE 2013, 8:e70233.
72. Lippmann E.S., et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 2012, 30:783-791.
73. Lippmann E.S., et al. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci. Rep. 2014, 4:4160.
74. Pardridge W.M. Drug transport across the blood-brain barrier. J. Cereb. Blood Flow Metab. 2012, 32:1959-1972.
75. Jones A.R., Shusta E.V. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm. Res. 2007, 24:1759-1771.
76. Yu Y.J., Watts R.J. Developing therapeutic antibodies for neurodegenerative disease. Neurotherapeutics 2013, 10:459-472.
77. Niewoehner J., et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 2014, 81:49-60.
78. McDannold N., et al. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012, 72:3652-3663.
79. Samiotaki G., et al. Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood-brain barrier opening in vivo. J. Cereb. Blood Flow Metab. 2015, 35:611-622.
80. Paes K.T., et al. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest. Ophthalmol. Vis. Sci. 2011, 52:6452-6461.